 | • レポートコード：QY20ST-06841 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のトロンビン阻害剤市場について種類別（アルガトロバン、アクチバーゼ、その他）、用途別（病院、専門医院、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・トロンビン阻害剤市場の概要 ・世界の主要地域別トロンビン阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のトロンビン阻害剤市場規模2015-2026：種類別（アルガトロバン、アクチバーゼ、その他） ・世界のトロンビン阻害剤市場規模2015-2026：用途別（病院、専門医院、その他） ・トロンビン阻害剤の北米市場規模2015-2020 ・トロンビン阻害剤のヨーロッパ市場規模2015-2020 ・トロンビン阻害剤の中国市場規模2015-2020 ・トロンビン阻害剤の日本市場規模2015-2020 ・トロンビン阻害剤の東南アジア市場規模2015-2020 ・トロンビン阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・トロンビン阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・トロンビン阻害剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Thrombin Inhibitor Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Thrombin Inhibitor market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Thrombin inhibitors are anticoagulants that bind to and inhibit the activity ofthrombin therefore prevent blood clot formation. Thrombin inhibitors inactivate freethrombin and also the thrombin that is bound to fibrin.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Thrombin Inhibitor market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Thrombin Inhibitor industry.
Based on our recent survey, we have several different scenarios about the Thrombin Inhibitor YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Thrombin Inhibitor will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Thrombin Inhibitor market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Thrombin Inhibitor market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Thrombin Inhibitor market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Thrombin Inhibitor market. The report also includes nautical information, where it shows Thrombin Inhibitor market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Thrombin Inhibitor market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Thrombin Inhibitor market.
Geographical Analysis:
Based on region, the global Thrombin Inhibitor market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Thrombin Inhibitor market are
Bristol-Myers Squibb
Bayer
Sanofi
Genentech
CSL
Abbott
Armetheon
Microbix Biosystems
Astrazeneca
Baxter
Emisphere Technologies
Johnson & Johnson
Merck
Segment by Type
Argatroban
Activase
Others
Segment by Application
Hospital
Specialist Clinic
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Thrombin Inhibitor market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Thrombin Inhibitor market.
• The market share of the global Thrombin Inhibitor market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Thrombin Inhibitor market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Thrombin Inhibitor market.
1 Thrombin Inhibitor Market Overview
1.1 Thrombin Inhibitor Product Scope
1.2 Thrombin Inhibitor Segment by Type
1.2.1 Global Thrombin Inhibitor Sales by Type (2020-2026)
1.2.2 Argatroban
1.2.3 Activase
1.2.4 Others
1.3 Thrombin Inhibitor Segment by Application
1.3.1 Global Thrombin Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Thrombin Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global Thrombin Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global Thrombin Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global Thrombin Inhibitor Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Thrombin Inhibitor Industry Impact
1.5.1 How the Covid-19 is Affecting the Thrombin Inhibitor Industry
1.5.1.1 Thrombin Inhibitor Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Thrombin Inhibitor Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Thrombin Inhibitor Players to Combat Covid-19 Impact
2 Thrombin Inhibitor Estimate and Forecast by Region
2.1 Global Thrombin Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Thrombin Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Thrombin Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global Thrombin Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global Thrombin Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Thrombin Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Thrombin Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Thrombin Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe Thrombin Inhibitor Estimates and Projections (2015-2026)
2.4.3 China Thrombin Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan Thrombin Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Thrombin Inhibitor Estimates and Projections (2015-2026)
2.4.6 India Thrombin Inhibitor Estimates and Projections (2015-2026)
3 Global Thrombin Inhibitor Competition Landscape by Players
3.1 Global Top Thrombin Inhibitor Players by Sales (2015-2020)
3.2 Global Top Thrombin Inhibitor Players by Revenue (2015-2020)
3.3 Global Thrombin Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin Inhibitor as of 2019)
3.4 Global Thrombin Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers Thrombin Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Thrombin Inhibitor Players (Opinion Leaders)
4 Global Thrombin Inhibitor Market Size by Type
4.1 Global Thrombin Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global Thrombin Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global Thrombin Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global Thrombin Inhibitor Price by Type (2014-2020)
4.2 Global Thrombin Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Thrombin Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Thrombin Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global Thrombin Inhibitor Price Forecast by Type (2021-2026)
5 Global Thrombin Inhibitor Market Size by Application
5.1 Global Thrombin Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global Thrombin Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global Thrombin Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global Thrombin Inhibitor Price by Application (2015-2020)
5.2 Global Thrombin Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Thrombin Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Thrombin Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Thrombin Inhibitor Price Forecast by Application (2021-2026)
3 North America Thrombin Inhibitor Market Facts & Figures
3.2 North America Thrombin Inhibitor Sales Market Share by Company (2015-2020)
3.3 North America Thrombin Inhibitor Sales Market Share by Type (2015-2020)
3.4 North America Thrombin Inhibitor Sales Market Share by Application (2015-2020)
4 Europe Thrombin Inhibitor Market Facts & Figures
4.2 Europe Thrombin Inhibitor Sales Market Share by Company (2015-2020)
4.3 Europe Thrombin Inhibitor Sales Market Share by Type (2015-2020)
4.4 Europe Thrombin Inhibitor Sales Market Share by Application (2015-2020)
5 China Thrombin Inhibitor Market Facts & Figures
5.2 China Thrombin Inhibitor Sales Market Share by Company (2015-2020)
5.3 China Thrombin Inhibitor Sales Market Share by Type (2015-2020)
5.4 China Thrombin Inhibitor Sales Market Share by Application (2015-2020)
6 Japan Thrombin Inhibitor Market Facts & Figures
6.2 Japan Thrombin Inhibitor Sales Market Share by Company (2015-2020)
6.3 Japan Thrombin Inhibitor Sales Market Share by Type (2015-2020)
6.4 Japan Thrombin Inhibitor Sales Market Share by Application (2015-2020)
7 Southeast Asia Thrombin Inhibitor Market Facts & Figures
7.2 Southeast Asia Thrombin Inhibitor Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Thrombin Inhibitor Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Thrombin Inhibitor Sales Market Share by Application (2015-2020)
8 India Thrombin Inhibitor Market Facts & Figures
8.2 India Thrombin Inhibitor Sales Market Share by Company (2015-2020)
8.3 India Thrombin Inhibitor Sales Market Share by Type (2015-2020)
8.4 India Thrombin Inhibitor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Thrombin Inhibitor Business
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Thrombin Inhibitor Corporation Information
12.1.2 Bristol-Myers Squibb Thrombin Inhibitor Business Overview and Total Revenue
12.1.3 Bristol-Myers Squibb Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol-Myers Squibb Thrombin Inhibitor Products Offered
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Bayer
12.2.1 Bayer Thrombin Inhibitor Corporation Information
12.2.2 Bayer Thrombin Inhibitor Business Overview and Total Revenue
12.2.3 Bayer Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Thrombin Inhibitor Products Offered
12.2.5 Bayer Recent Development
12.3 Sanofi
12.3.1 Sanofi Thrombin Inhibitor Corporation Information
12.3.2 Sanofi Thrombin Inhibitor Business Overview and Total Revenue
12.3.3 Sanofi Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Thrombin Inhibitor Products Offered
12.3.5 Sanofi Recent Development
12.4 Genentech
12.4.1 Genentech Thrombin Inhibitor Corporation Information
12.4.2 Genentech Thrombin Inhibitor Business Overview and Total Revenue
12.4.3 Genentech Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Genentech Thrombin Inhibitor Products Offered
12.4.5 Genentech Recent Development
12.5 CSL
12.5.1 CSL Thrombin Inhibitor Corporation Information
12.5.2 CSL Thrombin Inhibitor Business Overview and Total Revenue
12.5.3 CSL Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CSL Thrombin Inhibitor Products Offered
12.5.5 CSL Recent Development
12.6 Abbott
12.6.1 Abbott Thrombin Inhibitor Corporation Information
12.6.2 Abbott Thrombin Inhibitor Business Overview and Total Revenue
12.6.3 Abbott Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Abbott Thrombin Inhibitor Products Offered
12.6.5 Abbott Recent Development
12.7 Armetheon
12.7.1 Armetheon Thrombin Inhibitor Corporation Information
12.7.2 Armetheon Thrombin Inhibitor Business Overview and Total Revenue
12.7.3 Armetheon Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Armetheon Thrombin Inhibitor Products Offered
12.7.5 Armetheon Recent Development
12.8 Microbix Biosystems
12.8.1 Microbix Biosystems Thrombin Inhibitor Corporation Information
12.8.2 Microbix Biosystems Thrombin Inhibitor Business Overview and Total Revenue
12.8.3 Microbix Biosystems Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Microbix Biosystems Thrombin Inhibitor Products Offered
12.8.5 Microbix Biosystems Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Thrombin Inhibitor Corporation Information
12.9.2 Astrazeneca Thrombin Inhibitor Business Overview and Total Revenue
12.9.3 Astrazeneca Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Thrombin Inhibitor Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Baxter
12.10.1 Baxter Thrombin Inhibitor Corporation Information
12.10.2 Baxter Thrombin Inhibitor Business Overview and Total Revenue
12.10.3 Baxter Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Baxter Thrombin Inhibitor Products Offered
12.10.5 Baxter Recent Development
12.11 Emisphere Technologies
12.11.1 Emisphere Technologies Thrombin Inhibitor Corporation Information
12.11.2 Emisphere Technologies Thrombin Inhibitor Business Overview and Total Revenue
12.11.3 Emisphere Technologies Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Emisphere Technologies Thrombin Inhibitor Products Offered
12.11.5 Emisphere Technologies Recent Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Thrombin Inhibitor Corporation Information
12.12.2 Johnson & Johnson Thrombin Inhibitor Business Overview and Total Revenue
12.12.3 Johnson & Johnson Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Johnson & Johnson Thrombin Inhibitor Products Offered
12.12.5 Johnson & Johnson Recent Development
12.13 Merck
12.13.1 Merck Thrombin Inhibitor Corporation Information
12.13.2 Merck Thrombin Inhibitor Business Overview and Total Revenue
12.13.3 Merck Thrombin Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Merck Thrombin Inhibitor Products Offered
12.13.5 Merck Recent Development
13 Thrombin Inhibitor Manufacturing Cost Analysis
13.1 Thrombin Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Thrombin Inhibitor
13.4 Thrombin Inhibitor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Thrombin Inhibitor Distributors List
14.3 Thrombin Inhibitor Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Thrombin Inhibitor Sales (K Pieces) Growth Rate by Type (2020-2026)
Table 2. Global Thrombin Inhibitor Sales (K Pieces) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Thrombin Inhibitor Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Thrombin Inhibitor Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Thrombin Inhibitor Players to Combat Covid-19 Impact
Table 8. Global Market Thrombin Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Thrombin Inhibitor Sales (K Pieces) by Region (2015-2020)
Table 10. Global Thrombin Inhibitor Sales Market Share by Region (2015-2020)
Table 11. Global Thrombin Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Thrombin Inhibitor Revenue Share by Region (2015-2020)
Table 13. Global Thrombin Inhibitor Sales (K Pieces) Forecast by Region (2021-2026)
Table 14. Global Thrombin Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Thrombin Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Thrombin Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 17. Global Thrombin Inhibitor (K Pieces) of Key Companies (2015-2020)
Table 18. Global Thrombin Inhibitor Sales Share by Company (2015-2020)
Table 19. Global Thrombin Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Thrombin Inhibitor Revenue Share by Company (2015-2020)
Table 21. Global Thrombin Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin Inhibitor as of 2019)
Table 22. Global Thrombin Inhibitor Average Price (USD/Piece) of Key Company (2015-2020)
Table 23. Manufacturers Thrombin Inhibitor Manufacturing Sites and Area Served
Table 24. Manufacturers Thrombin Inhibitor Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Thrombin Inhibitor Players
Table 27. Global Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 28. Global Thrombin Inhibitor Sales Share by Type (2015-2020)
Table 29. Global Thrombin Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Thrombin Inhibitor Price (K Pieces) by Type (2015-2020)
Table 31. Global Thrombin Inhibitor Sales Share by Type (2021-2026)
Table 32. Global Thrombin Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Thrombin Inhibitor Revenue Share by Type (2021-2026)
Table 34. Global Thrombin Inhibitor Price (K Pieces) by Type (2021-2026)
Table 35. Global Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 36. Global Thrombin Inhibitor Sales Share by Application (2015-2020)
Table 37. Global Thrombin Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Thrombin Inhibitor Price (K Pieces) by Application (2015-2020)
Table 39. Global Thrombin Inhibitor Sales (K Pieces) by Application (2021-2026)
Table 40. Global Thrombin Inhibitor Sales Share by Application (2021-2026)
Table 41. Global Thrombin Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Thrombin Inhibitor Revenue Share by Application (2021-2026)
Table 43. Global Thrombin Inhibitor Price (K Pieces) by Application (2021-2026)
Table 44. United States Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 45. United States Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 46. United States Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 47. United States Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 48. United States Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 49. United States Thrombin Inhibitor Sales Market Share by Application (2015-2020)
Table 50. Europe Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 51. Europe Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 52. Europe Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 53. Europe Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 54. Europe Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 55. Europe Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 56. China Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 57. China Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 58. China Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 59. China Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 60. China Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 61. China Thrombin Inhibitor Sales Market Share by Application (2015-2020)
Table 62. Japan Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 63. Japan Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 64. Japan Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 65. Japan Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 66. Japan Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 67. Japan Thrombin Inhibitor Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 69. Southeast Asia Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 71. Southeast Asia Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 73. Southeast Asia Thrombin Inhibitor Sales Market Share by Application (2015-2020)
Table 74. India Thrombin Inhibitor Sales (K Pieces) by Company (2015-2020)
Table 75. India Thrombin Inhibitor Sales Market Share by Company (2015-2020)
Table 76. India Thrombin Inhibitor Sales (K Pieces) by Type (2015-2020)
Table 77. India Thrombin Inhibitor Sales Market Share by Type (2015-2020)
Table 78. India Thrombin Inhibitor Sales (K Pieces) by Application (2015-2020)
Table 79. India Thrombin Inhibitor Sales Market Share by Application (2015-2020)
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb Thrombin Inhibitor Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 88. Bayer Thrombin Inhibitor Product
Table 89. Bayer Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 93. Sanofi Thrombin Inhibitor Product
Table 94. Sanofi Recent Development
Table 95. Genentech Corporation Information
Table 96. Genentech Description and Business Overview
Table 97. Genentech Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 98. Genentech Thrombin Inhibitor Product
Table 99. Genentech Recent Development
Table 100. CSL Corporation Information
Table 101. CSL Description and Business Overview
Table 102. CSL Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 103. CSL Thrombin Inhibitor Product
Table 104. CSL Recent Development
Table 105. Abbott Corporation Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 108. Abbott Thrombin Inhibitor Product
Table 109. Abbott Recent Development
Table 110. Armetheon Corporation Information
Table 111. Armetheon Description and Business Overview
Table 112. Armetheon Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 113. Armetheon Thrombin Inhibitor Product
Table 114. Armetheon Recent Development
Table 115. Microbix Biosystems Corporation Information
Table 116. Microbix Biosystems Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 117. Microbix Biosystems Description and Business Overview
Table 118. Microbix Biosystems Thrombin Inhibitor Product
Table 119. Microbix Biosystems Recent Development
Table 120. Astrazeneca Corporation Information
Table 121. Astrazeneca Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 122. Astrazeneca Description and Business Overview
Table 123. Astrazeneca Thrombin Inhibitor Product
Table 124. Astrazeneca Recent Development
Table 125. Baxter Corporation Information
Table 126. Baxter Description and Business Overview
Table 127. Baxter Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 128. Baxter Thrombin Inhibitor Product
Table 129. Baxter Recent Development
Table 130. Emisphere Technologies Corporation Information
Table 131. Emisphere Technologies Description and Business Overview
Table 132. Emisphere Technologies Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 133. Emisphere Technologies Thrombin Inhibitor Product
Table 134. Emisphere Technologies Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table 138. Johnson & Johnson Thrombin Inhibitor Product
Table 139. Johnson & Johnson Recent Development
Table . Merck Corporation Information
Table . Merck Description and Business Overview
Table . Merck Thrombin Inhibitor Sales (K Pieces), Revenue (Million USD), Price (USD/Piece) and Gross Margin (2015-2020)
Table . Merck Thrombin Inhibitor Product
Table . Merck Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Thrombin Inhibitor Distributors List
Table 148. Thrombin Inhibitor Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin Inhibitor Product Picture
Figure 2. Global Thrombin Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Thrombin Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Specialist Clinic Examples
Figure 8. Others Examples
Figure 9. Global Thrombin Inhibitor Sales (K Pieces) Growth Rate (2015-2026)
Figure 10. Global Thrombin Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Thrombin Inhibitor Price Trends Growth Rate (2015-2026) (USD/Piece)
Figure 12. Global Thrombin Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Thrombin Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Thrombin Inhibitor Sales (K Pieces) Growth Rate (2015-2026)
Figure 16. Europe Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Thrombin Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Thrombin Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Thrombin Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Thrombin Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Thrombin Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Thrombin Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Thrombin Inhibitor Players Market Share by Revenue in Thrombin Inhibitor 2015 & 2019
Figure 27. Thrombin Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Thrombin Inhibitor Revenue Share by Type (2015-2020)
Figure 29. Global Thrombin Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Thrombin Inhibitor Revenue Share by Application (2015-2020)
Figure 31. Global Thrombin Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 33. United States Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 34. Europe Thrombin Inhibitor Sales Market Share by Company in 2019
Figure 35. Europe Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 36. Europe Thrombin Inhibitor Sales Market Share by Application in 2019
Figure 37. China Thrombin Inhibitor Sales Market Share by Company in 2019
Figure 38. China Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 39. China Thrombin Inhibitor Sales Market Share by Application in 2019
Figure 40. Japan Thrombin Inhibitor Sales Market Share by Company in 2019
Figure 41. Japan Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 42. Japan Thrombin Inhibitor Sales Market Share by Application in 2019
Figure 43. Southeast Asia Thrombin Inhibitor Sales Market Share by Company in 2019
Figure 44. Southeast Asia Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 45. Southeast Asia Thrombin Inhibitor Sales Market Share by Application in 2019
Figure 46. India Thrombin Inhibitor Sales Market Share by Company in 2019
Figure 47. India Thrombin Inhibitor Sales Market Share by Type in 2019
Figure 48. India Thrombin Inhibitor Sales Market Share by Application in 2019
Figure 49. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Armetheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Microbix Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Emisphere Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Thrombin Inhibitor
Figure 64. Manufacturing Process Analysis of Thrombin Inhibitor
Figure 65. Thrombin Inhibitor Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
免疫抑制剤の世界市場レポート2020 A recently published report by QY Research titled Global Immune Anti-Inhibitor Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…- SGLT2阻害剤の世界市場レポート2020 Market Analysis and Insights: Global SGLT2 Inhibitor Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 201…
- 酸化物抑制剤の世界市場レポート2020 A recently published report by QY Research titled Global Oxide Inhibitor Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- 揮発性腐食防止剤バッグの世界市場レポート2020 A recently published report by QY Research titled Global Volatile Corrosion Inhibitor Bag Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pro…
- 揮発性腐食防止剤バッグの世界市場レポート2020 A recently published report by QY Research titled Global Volatile Corrosion Inhibitor Bag Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pro…